84371-57-3Relevant articles and documents
Discovery of a Potent and Selective Steroidal Glucocorticoid Receptor Antagonist (ORIC-101)
Rew, Yosup,Du, Xiaohui,Eksterowicz, John,Zhou, Haiying,Jahchan, Nadine,Zhu, Liusheng,Yan, Xuelei,Kawai, Hiroyuki,McGee, Lawrence R.,Medina, Julio C.,Huang, Tom,Chen, Chelsea,Zavorotinskaya, Tatiana,Sutimantanapi, Dena,Waszczuk, Joanna,Jackson, Erica,Huang, Elizabeth,Ye, Qiuping,Fantin, Valeria R.,Sun, Daqing
, p. 7767 - 7784 (2018/09/06)
The glucocorticoid receptor (GR) has been linked to therapy resistance across a wide range of cancer types. Preclinical data suggest that antagonists of this nuclear receptor may enhance the activity of anticancer therapy. The first-generation GR antagonist mifepristone is currently undergoing clinical evaluation in various oncology settings. Structure-based modification of mifepristone led to the discovery of ORIC-101 (28), a highly potent steroidal GR antagonist with reduced androgen receptor (AR) agonistic activity amenable for dosing in androgen receptor positive tumors and with improved CYP2C8 and CYP2C9 inhibition profile to minimize drug-drug interaction potential. Unlike mifepristone, 28 could be codosed with chemotherapeutic agents readily metabolized by CYP2C8 such as paclitaxel. Furthermore, 28 demonstrated in vivo antitumor activity by enhancing response to chemotherapy in the GR+ OVCAR5 ovarian cancer xenograft model. Clinical evaluation of safety and therapeutic potential of 28 is underway.
Phase-Transfer catalysed enantioselective epoxidation of Estra-δ5(10),9(11)- diene using chiral ammonium salts derived from cinchona alkaloids
Yang, Ya-Xi,Li, Zheng,Chen, Guo-Rong,Li, Yuan-Chao
experimental part, p. 163 - 167 (2010/09/03)
A modified phase-transfer catalysed enantioselective epoxidation of estra-δ5(10),9(11)-diene, an important intermediate of anti-early pregnancy drug mifepristone 1, have been determined and investigated. Eight chiral ammonium salts (PTC A-H), used as phase-transfer catalysts, have been synthesized from cinchona alkaloids. Among them, PTC G and PTC H have exhibited satisfying catalytic activity to improve the ratio of α/β. epoxide up to 7:1.
11-PHOSPHOROUS STEROID DERIVATIVES USEFUL AS PROGESTERONE RECEPTOR MODULATORS
-
Page/Page column 30, (2010/11/28)
The present invention is directed to novel 11-phosphorous steroid derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by a progesterone or glucocorticoid receptor.